Cargando…
Vitamin D3 Priming of Dendritic Cells Shifts Human Neutrophil-Dependent Th17 Cell Development to Regulatory T Cells
Vitamin D3 (VD3) is a potential adjuvant for use in tolerogenic vaccine formulations that target dendritic cells (DCs) for the treatment of chronic inflammatory disorders, e.g., autoimmune diseases. These disorders are often associated with enhanced activity of IL-17-producing T helper 17 (Th17) cel...
Autores principales: | Hafkamp, Florianne M. J., Taanman-Kueter, Esther W. M., van Capel, Toni M. M., Kormelink, Tom Groot, de Jong, Esther C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301463/ https://www.ncbi.nlm.nih.gov/pubmed/35874744 http://dx.doi.org/10.3389/fimmu.2022.872665 |
Ejemplares similares
-
Efficient Neutrophil Activation Requires Two Simultaneous Activating Stimuli
por: Mol, Sanne, et al.
Publicado: (2021) -
Targeting DCs for Tolerance Induction: Don’t Lose Sight of the Neutrophils
por: Hafkamp, Florianne M. J., et al.
Publicado: (2021) -
Dexamethasone, but Not Vitamin D or A, Dampens the Inflammatory Neutrophil Response to Protect At-risk COVID-19 Patients
por: Hafkamp, Florianne M.J., et al.
Publicado: (2022) -
Hyaluronic Acid in Synovial Fluid Prevents Neutrophil Activation in Spondyloarthritis
por: Mol, Sanne, et al.
Publicado: (2023) -
VSTM1-v2 does not drive human Th17 cell differentiation: A replication study
por: von Richthofen, Helen J., et al.
Publicado: (2023)